FDA has approved pyridostigmine bromide to increase survival after exposure to the nerve agent Soman. Pyridostigmine bromide is approved only for combat use by U.S. military personnel.
- FDA Press Release
- Pyridostigmine Bromide Approval Letter
- Drug Label (2/10/02)
- Questions and Answers on Pyridostigmine Bromide (FDA Archive)
- Federal Register Notice; Final Rule. New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible. [TXT] [PDF]